Why GE HealthCare Technologies Inc. (GEHC) stock moved
No significant move on Nov 16, 2026 (−0.1%, close-to-close). Latest notable session: Nov 4, 2026.
Why GE HealthCare Technologies Inc. (GEHC) rose 6.4% on November 4, 2026
GE HealthCare Technologies Inc. (GEHC) rose 6.4% on November 4, 2026, closing at $85.81 versus $80.66 the prior session (close-to-close, from daily closes). Following the launch of Lung Guidance and AutoAS AI features for its Vscan Air handheld ultrasound system. Source: FMP price data; BestStocks detection.
GE HealthCare Technologies Inc. (GEHC) moved +3.42% from $82.97 to $85.81 on November 4, 2026, following the launch of Lung Guidance and AutoAS AI features for its Vscan Air handheld ultrasound system.
What to watch next: GEHC earnings are scheduled for February 3, 2027, where management may provide guidance on adoption of the Vscan Air AI features and their revenue impact.
Earlier sessions that moved GEHC
- +3.9%GE HealthCare Technologies beat third-quarter earnings expectations and raised its 2026 full-year guidance, according to the web catalyst, driving a 3.98% intraday rally to $79.62.
- +6.6%The beat drove the intraday rally; volume data remains unreliable 45 minutes into the session. Read the October 28, 2026 analysis →
- +3.5%After breaking through its 200-day moving average on August 11 (per Zacks).
- +2.7%After the company announced that its MINItrace Magni cyclotron achieved CE Mark and its PETtrace platform expanded to Copper-64 isotopes.
- +3.0%Driven by sustained investor enthusiasm following its $945 million acquisition of SOFIE Biosciences announced last week.
- −3.0%As part of a broader healthcare sector pullback affecting major components like the XLV healthcare ETF, compounded by investor scrutiny of an upcoming CFO transition (William K. Grogan effective September 14).
GE HealthCare Technologies Inc. (GEHC) shares fell 0.1% to $82.96 as of November 16, 2026, a slight decline from the prior close of $83.02. BestStocks flagged the session as a major change for GEHC. The move is tied to company news. Below, we break down what changed for GEHC, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Company News
GEHC establishes MAGNUS Neuro Alliance collaborative network to advance neuroscience MRI research capabilities. Alliance positions GEHC in high-growth neuroscience imaging market, potentially generating new revenue streams and competitive differentiation.
What it means for GE HealthCare Technologies Inc. investors
For GE HealthCare Technologies Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 0.1%; GE HealthCare Technologies (GEHC) declined 6.32% to $61.18 as options market activity drew investor attention. Wall Street's consensus price target sits at $81.22, implying -2.1% downside from $82.96. BestStocks rates the overall signal quality weak (32/100). With earnings roughly 79 days out, the next report is the most likely near-term test of the move.
GEHC price reaction
GEHC last traded at $82.96, down $0.06 (-0.07%) from the previous close of $83.02. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $69.01 and $85.81, and it currently sits about 83% of the way up that band.
Bullish and bearish analyst opinions on GE HealthCare Technologies Inc. (GEHC)
The consensus analyst price target on GE HealthCare Technologies Inc. (GEHC) is $81.22, 2.1% below the recent $82.96. Over the past 90 days analysts logged 0 upgrades, 12 maintains, and 0 downgrades. Here is how the bullish and bearish cases on GEHC line up.
The bullish case
- The Street's most bullish target is $95.00 (+14.5%).
- Positive price momentum.
The bearish case
- The consensus analyst price target of $81.22 sits 2.1% below the recent $82.96, so the average target sees limited room to run.
- The most bearish analyst target is $67.00 (-19.2%).
- Negative session, down 0.1%.
- GE HealthCare Technologies (GEHC) declined 6.32% to $61.18 as options market activity drew investor attention.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 16, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for GEHC
In-depth GEHC event analyses
Frequently asked questions about GEHC
Why did GE HealthCare Technologies Inc. (GEHC) stock move?
GE HealthCare Technologies Inc. (GEHC) rose 6.4% on November 4, 2026, closing at $85.81 versus $80.66 the prior session (close-to-close, from daily closes). Following the launch of Lung Guidance and AutoAS AI features for its Vscan Air handheld ultrasound system. Source: FMP price data; BestStocks detection.
How much did GEHC stock fall?
GEHC lost 0.07% ($0.06) versus the prior close of $83.02, last trading at $82.96 on 0.8× average volume.
When is GE HealthCare Technologies Inc.'s next earnings date?
GEHC's next earnings report is estimated for 2027-02-03 — about 79 days away.
What is the analyst price target for GEHC?
The consensus analyst price target for GEHC is $81.22, about 2.1% below the current $82.96. Over the past 90 days, analysts recorded 0 upgrades, 12 maintains, and 0 downgrades.
How BestStocks tracks GEHC
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for GEHC, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 16, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
